Precision medicine is personalized healthcare model exclusively designed for an individual. The procedure considers various factors affecting patient such as environment, lifestyle, and individual variability in genes. Most suitable medical therapies are constructed depending upon primary diagnosis of disease and patient’s genomic framework. The global precision medicine market accounted for $3,516 million in 2016, and is estimated to reach at $7,746 million by 2023, registering a CAGR of 11.9% from 2017 to 2023. Research Beam Model: Research Beam Product ID: 2109086 5370 USD New
Precision Medicine Market by Technology (Genomics, Transcriptomics and Epigenomics), by Sequencing Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Chain Termination Sequencing and Nanopore Sequencing), Product (Consumables, Instruments and Services) Application (Oncology, CNS, Immunology, Respiratory Medicine, Infections, and Other Applications) End User (Diagnostic Tool companies, Pharma & Biotech Companies, Clinical Laboratories, and Healthcare IT/Big Data Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Precision Medicine Market by Technology (Genomics, Transcriptomics and Epigenomics), by Sequencing Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Chain Termination Sequencing and Nanopore Sequencing), Product (Consumables, Instruments and Services) Application (Oncology, CNS, Immunology, Respiratory Medicine, Infections, and Other Applications) End User (Diagnostic Tool companies, Pharma & Biotech Companies, Clinical Laboratories, and Healthcare IT/Big Data Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

 
  • Category : Healthcare
  • Published On : June  2017
  • Pages : 150
 
 

Precision medicine is personalized healthcare model exclusively designed for an individual. The procedure considers various factors affecting patient such as environment, lifestyle, and individual variability in genes. Most suitable medical therapies are constructed depending upon primary diagnosis of disease and patient’s genomic framework. The global precision medicine market accounted for $3,516 million in 2016, and is estimated to reach at $7,746 million by 2023, registering a CAGR of 11.9% from 2017 to 2023.

Precision medicine allows doctors and researchers to estimate specific medications that work best against a particular type of disease in a set group of people. Similar therapeutic treatments are then carried out in case of people responding to the treatments with a positive outlook. Which excludes patients showing side effects or any unwanted results regarding treatment.

Government initiatives and huge investment by private companies into R&D drive the precision medicine market. Moreover, growth in aging population and rise in global incidences of cancer are anticipated to boost the market growth. Application of high throughput genomic technologies in biomedical research and therapeutic procedures accelerate market progression.

The precision medicine market is segmented based on technology, sequencing technology, product, applications, and geography. Based on technology, it is divided into genomics, transcriptomics and epigenomics. Based on sequencing technology, the market is bifurcated into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, chain termination sequencing and nanopore sequencing. Based on product, the precision medicine market is subdivided into consumables, instruments and services.

Based on applications, it is classified into oncology, CNS, immunology, respiratory medicine, infections, and other applications. Based on end users, it is categorized into diagnostic tool companies, pharma & biotech companies, clinical laboratories, and healthcare IT/big data companies. Geographically, it is analyzed based on four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS

The study provides an in-depth analysis of the global precision medicine market and the current trends and future estimations to elucidate the imminent investment pockets.
The report presents quantitative analysis of the market from 2016 to 2023 to enable stakeholders capitalize on the prevailing market opportunities.
Extensive analysis of the market based on sequencing technology assists to understand the trends in the industry.
Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Precision Medicine Market Segments:

By Technology

  • Genomics
  • Transcriptomics
  • Epigenomics

By Sequencing Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Single Molecule Real Time Sequencing
  • Chain Termination Sequencing
  • Nanopore Sequencing

By Product

  • Consumables
  • Instruments
  • Services

By Application

  • Oncology
  • CNS
  • Immunology
  • Respiratory Medicine
  • Infections
  • Others Applications

By End user

  • Diagnostic Tool companies
  • Pharma & Biotech Companies
  • Clinical Laboratories
  • Healthcare IT/ Big Data Companies

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. TOP PLAYER POSITIONING
3.4. PATENTS ANALYSIS

3.4.1. Patent analysis by year
3.4.2. Patent analysis by region

3.5. PORTERS FIVE FORCES ANALYSIS
3.6. MARKET DYNAMICS

3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities

CHAPTER 4 GLOBAL PRECISION MEDICINE MARKET, BY TECHNOLOGY

4.1. OVERVIEW

4.1.1. Market size & forecast

4.2. GENOMICS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast

4.3. TRANSCRIPTOMICS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast

4.4. EPIGENOMICS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast

CHAPTER 5 GLOBAL PRECISION MEDICINE MARKET, BY SEQUENICNG TECHNOLOGY

5.1. OVERVIEW

5.1.1. Market size & forecast

5.2. SEQEUNCING BY SYNTHESIS (SBS)

5.2.1. Market size & forecast

5.3. ION SEMICONDUCTOR SEQUENCING (ISS)

5.3.1. Market size & forecast

5.4. SEQEUNCING BY LIGATION (SBL)

5.4.1. Market size & forecast

5.5. PYROSEQUENCING

5.5.1. Market size & forecast

5.6. SINGLE MOLECULE REAL TIME SEQUENCING (SMRT)

5.6.1. Market size & forecast

5.7. NANOPORE SEQUENCING

5.7.1. Market size & forecast

CHAPTER 6 GLOBAL PRECISION MEDICINE MARKET, BY PRODUCT

6.1. OVERVIEW

6.1.1. Market size & forecast

6.2. CONSUMABLES

6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size & forecast

6.3. INSTRUMENTS

6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size & forecast

6.4. SERVICES

6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size & forecast

CHAPTER 7 GLOBAL PRECISION MEDICINE MARKET, BY APPLICATION

7.1. OVERVIEW

7.1.1. Market size & forecast

7.2. ONCOLOGY

7.2.1. Market size & forecast

7.3. CENTRAL NERVOUS SYSTEM (CNS)

7.3.1. Market size & forecast

7.4. IMMUNOLOGY

7.4.1. Market size & forecast

7.5. RESPIRATORY MEDICINE

7.5.1. Market size & forecast

7.6. INFECTION

7.6.1. Market size & forecast

7.7. OTHER APPLICATION

7.7.1. Market size & forecast

CHAPTER 8 GLOBAL PRECISION MEDICINE MARKET, BY END USERS

8.1. OVERVIEW

8.1.1. Market size & forecast

8.2. PHARMA & BIOTECH COMPANIES

8.2.1. Market size & forecast

8.3. DIAGNOSTIC TOOL COMPANIES

8.3.1. Market size & forecast

8.4. HEALTHCARE IT/ BIG DATA COMPANIES

8.4.1. Market size & forecast

8.5. CLINICAL LABORATORIES

8.5.1. Market size & forecast

CHAPTER 9 GLOBAL PRECISION MEDICINE MARKET, BY GEOGRAPHY

9.1. OVERVIEW
9.2. NORTH AMERICA

9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size & forecast

9.2.3.1. U.S. market size and forecast
9.2.3.2. Canada market size and forecast
9.2.3.3. Mexico market size and forecast

9.3. EUROPE

9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size & forecast

9.3.3.1. Germany market size and forecast
9.3.3.2. France market size and forecast
9.3.3.3. UK market size and forecast
9.3.3.4. Italy market size and forecast
9.3.3.5. Spain market size and forecast
9.3.3.6. Rest of Europe market size and forecast

9.4. ASIA-PACIFIC

9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Market size & forecast

9.4.3.1. Japan market size and forecast
9.4.3.2. China market size and forecast
9.4.3.3. Australia market size and forecast
9.4.3.4. India market size and forecast
9.4.3.5. South Korea market size and forecast
9.4.3.6. Taiwan market size and forecast
9.4.3.7. Rest of Asia-Pacific market size and forecast

9.5. LAMEA

9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size & forecast

9.5.3.1. Brazil market size and forecast
9.5.3.2. Turkey market size and forecast
9.5.3.3. Saudi Arabia market size and forecast
9.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 10 COMPANY PROFILES

10.1. ILLUMINA, INC

10.1.1. Operating business segments
10.1.2. Business performance
10.1.3. Key strategic moves and developments

10.2. THERMO FISHER SCIENTIFIC, INC

10.2.1. Operating business segments
10.2.2. Business performance
10.2.3. Key strategic moves and developments

10.3. ROCHE HOLDING AG (ROCHE)

10.3.1. Operating business segments
10.3.2. Business performance
10.3.3. Key strategic moves and developments

10.4. LABORATORY CORPORATION OF AMERICA HOLDINGS (LCAH)

10.4.1. Operating business segments
10.4.2. Business performance
10.4.3. Key strategic moves and developments

10.5. QUEST DIAGNOSTICS (QD)

10.5.1. Operating business segments
10.5.2. Business performance
10.5.3. Key strategic moves and developments

10.6. QIAGEN N.V.,

10.6.1. Operating business segments
10.6.2. Business performance
10.6.3. Key strategic moves and developments

10.7. ASTRAZENECA

10.7.1. Operating business segments
10.7.2. Business performance
10.7.3. Key strategic moves and developments

10.8. NOVARTIS AG (NAG)

10.8.1. Operating business segments
10.8.2. Business performance
10.8.3. Key strategic moves and developments

10.9. BRISTOL-MYERS SQUIBB (BMS)

10.9.1. Operating business segments
10.9.2. Business performance
10.9.3. Key strategic moves and developments

10.10. ELI LILLY & COMPANY (ELC)

10.10.1. Operating business segments
10.10.2. Business performance
10.10.3. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL PRECISION MEDICINE MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 2. GENOMICS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. TRANSCRIPTOMICS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. EPIGENOMICS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL PRECISION MEDICINE MARKET, BY SEQUENCING TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 6. SBS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. ISS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 8. SBL PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. PYROSEQUENCING PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. SMRT PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. NANOPORE SEQUENCING PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL PRECISION MEDICINE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 13. CONSUMABLES PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. INSTRUMENTS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. SERVICES PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL PRECISION MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 17. ONCOLOGY PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 18. CNS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. IMMUNOLOGY PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. RESPIRATORY MEDICINE PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 21. INFECTION PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. OTHER APPLICATION PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL PRECISION MEDICINE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 24. PHARMA & BIOTECH COMPANIES PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 25. PHARMACEUTICAL COMPANY PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 26. HEALTHCARE IT/ BIG DATA COMPANIES PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 27. CLINICAL LABORATORIES PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA PRECISION MEDICINE MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA PRECISION MEDICINE MARKET, BY SEQUENCING TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA PRECISION MEDICINE MARKET, BY PRODUCT 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA PRECISION MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA PRECISION MEDICINE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 35. EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 36. EUROPE PRECISION MEDICINE MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 37. EUROPE PRECISION MEDICINE MARKET, BY SEQUENCING TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 38. EUROPE PRECISION MEDICINE MARKET, BY PRODUCT 2016-2023 ($MILLION)
TABLE 39. EUROPE PRECISION MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 40. EUROPE PRECISION MEDICINE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 41. ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 42. ASIA-PACIFIC PRECISION MEDICINE MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 43. ASIA-PACIFIC PRECISION MEDICINE MARKET, BY SEQUENCING TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 44. ASIA-PACIFIC PRECISION MEDICINE MARKET, BY PRODUCT 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC PRECISION MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC PRECISION MEDICINE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 47. LAMEA PRECISION MEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 48. LAMEA PRECISION MEDICINE MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 49. LAMEA PRECISION MEDICINE MARKET, BY SEQUENCING TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 50. LAMEA PRECISION MEDICINE MARKET, BY PRODUCT 2016-2023 ($MILLION)
TABLE 51. LAMEA PRECISION MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 52. LAMEA PRECISION MEDICINE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 53. ILLUMINA, INC: COMPANY SNAPSHOT
TABLE 54. THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT
TABLE 55. ROCHE: COMPANY SNAPSHOT
TABLE 56. LCAH: COMPANY SNAPSHOT
TABLE 57. QD: COMPANY SNAPSHOT
TABLE 58. QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 59. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 60. NAG: COMPANY SNAPSHOT
TABLE 61. BMS: COMPANY SNAPSHOT
TABLE 62. ELC: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. PRECISION MEDICINE MARKET: MARKET SEGMENATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL DNA SEQUENCING MARKET, BY APPLICATION
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 5. TOP PLAYER POSITIONING: GLOBAL PRECISION MEDICINE MARKET
FIGURE 6. PATENT ANALYSIS BY REGION
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. PRECISION MEDICINE MARKET: TECHNOLOGY SEGMENATION
FIGURE 13. PRECISION MEDICINE MARKET: SEQUENCING TECHNOLOGY SEGMENATION
FIGURE 14. PRECISION MEDICINE MARKET: PRODUCT SEGMENATION
FIGURE 15. U.S. PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 16. CANADA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 17. MEXICO PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 18. GERMANY PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 19. FRANCE PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 20. UK PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 21. ITALY PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 22. SPAIN PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 23. REST OF EUROPE PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 24. JAPAN PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 25. CHINA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 26. AUSTRALIA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 27. INDIA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 28. SOUTH KOREA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 29. TAIWAN PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 30. REST OF ASIA-PACIFIC PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 31. BRAZIL PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 32. TURKEY PRECISION MEDICINE MARKET, 2016-20223 ($MILLION)
FIGURE 33. SAUDI ARABIA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 34. REST OF LAMEA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)